The critical difference is mechanism type
Approved in Austria, Russia, China, South Korea, and other countries for Alzheimer's disease, post-stroke recovery, and traumatic brain injury
high resistance to enzymatic degradation TB-500 (Thymosin Beta-4 fragment) Active domain: Ac-LKKTETQ Molecular formula: CHNO Molecular weight: 889 Da Regulates actin polymerization and cytoskeletal dynamics The blend is provided as a single lyophilized acetate salt powder
These links support catalog navigation and do not imply equivalence or use
It gets injected under the skin, reaches cells quickly, inhibits NNMT (overactive in fat tissue), preserves more NAD+ for energy production, reduces fat storage, and encourages the body to burn fat as fuel